Title
Cost-effectiveness of Tolcapone (Tasmar) vs. Ropinirole (Requip) patients on levodopa therapy from a payer perspective
Document Type
Presentation
Date of Publication
9-1999
Event
VCU/MCV School of Pharmacy Research Day
Recommended Citation
Nye, A. M.; Garnett, W.; Holdford, D.; and Carroll, N., "Cost-effectiveness of Tolcapone (Tasmar) vs. Ropinirole (Requip) patients on levodopa therapy from a payer perspective" (1999). Pharmacy Practice. 681.
https://cufind.campbell.edu/pharmacypractice/681
COinS
